Cigna Group
CI
View Detailed Chart
297.503USD
-5.257-1.74%
Market hours （ET）Quotes delayed by 15 min
79.31BMarket Cap
15.81P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-1.74%
5 Days
-2.56%
1 Month
+2.46%
6 Months
-4.92%
Year to Date
+7.74%
1 Year
-18.43%
View Detailed Chart
TradingKey Stock Score
Currency: USD Updated：2025-09-12Key Insights
The company's fundamentals are relatively healthy. Its valuation is considered undervalued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a weak stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
26
analysts
Buy
Current Rating
361.486
Target Price
+19.40%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Company Highlights
StrengthsRisks
The Cigna Group is a global health company. The Company has two growth platforms: Evernorth Health Services and Cigna Healthcare. The Company’s portfolio of offerings solves diverse challenges across the healthcare system. Evernorth Health Services includes a range of independent and coordinated health solutions and capabilities designed to enable the healthcare system to help people live richer, healthier lives. Health plans, employers, governmental organizations and health care providers partner with Evernorth Health Services to solve their challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions. Cigna Healthcare includes the United States healthcare and international health businesses, which provide comprehensive medical and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI) and the Company's run-off operations.
Industry Leader
The company's revenue leads the industry, with the latest annual revenue totaling USD 247.12B.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 36.90% year-on-year.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 45.63%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 45.63%.
Fairly Valued
The company’s latest PE is 16.45, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 245.93M shares, decreasing 3.95% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 25.60M shares of this stock.
News
More news coming soon, stay tuned...
Financial Indicators
EPS
No Data
Total revenue
No Data
Company
The Cigna Group is a global health company. The Company has two growth platforms: Evernorth Health Services and Cigna Healthcare. The Company’s portfolio of offerings solves diverse challenges across the healthcare system. Evernorth Health Services includes a range of independent and coordinated health solutions and capabilities designed to enable the healthcare system to help people live richer, healthier lives. Health plans, employers, governmental organizations and health care providers partner with Evernorth Health Services to solve their challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions. Cigna Healthcare includes the United States healthcare and international health businesses, which provide comprehensive medical and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI) and the Company's run-off operations.
Ticker SymbolCI
CompanyCigna Group
CEOMr. David M. Cordani, CPA
Websitehttps://www.thecignagroup.com/
